Cell line name |
MFUM-BrTNBC-1 |
Synonyms |
Medical Faculty University of Maribor-Breast Triple Negative Breast Cancer-1 |
Accession |
CVCL_B5N7 |
Resource Identification Initiative |
To cite this cell line use: MFUM-BrTNBC-1 (RRID:CVCL_B5N7) |
Comments |
Group: Triple negative breast cancer (TNBC) cell line. Population: Caucasian; Slovenian. Characteristics: Shown by ICC and PCR to be ER-negative, PR-negative and ERBB2-negative (PubMed=35011679). Doubling time: 80 hours (PubMed=35011679). Derived from site: In situ; Breast; UBERON=UBERON_0000310. |
Sequence variations |
- Mutation; HGNC; HGNC:393; AKT3; Simple; p.Lys294Ter (c.880A>T); Zygosity=Heterozygous (PubMed=35011679).
- Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Tyr2037Ter (c.6111C>G); Zygosity=Heterozygous (PubMed=35011679).
- Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly32Arg (c.94G>C); ClinVar=VCV001690925; Zygosity=Heterozygous (PubMed=35011679).
- Mutation; HGNC; HGNC:7993; NRBP1; Simple; p.Lys217Ter (c.649A>T); Zygosity=Heterozygous (PubMed=35011679).
- Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=35011679).
- Mutation; HGNC; HGNC:12816; XPC; Simple; p.Gln829Ter (c.2485C>T); Zygosity=Heterozygous (PubMed=35011679).
|
Disease |
Invasive breast carcinoma of no special type (NCIt: C4194) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Sex of cell |
Female |
Age at sampling |
47Y |
Category |
Cancer cell line |
STR profile |
Source(s): PubMed=35011679
Markers:Amelogenin | X |
CSF1PO | 11 |
D2S1338 | 22,24 |
D3S1358 | 15 |
D5S818 | 12 |
D7S820 | 9,11 |
D8S1179 | 12,14 |
D13S317 | 13,14 |
D16S539 | 11,12 |
D18S51 | 12,16 |
D19S433 | 13,14 |
D21S11 | 28,31.2 |
FGA | 23 |
TH01 | 6 |
TPOX | 8,9 |
vWA | 17,19 |
Run an STR similarity search on this cell line |
Publications | PubMed=31749235; DOI=10.1111/tbj.13695 Skok K., Gradisnik L., Celesnik H.S., Potocnik U., Kavalar R., Takac I., Maver U. Isolation and characterization of the first Slovenian human triple-negative breast cancer cell line. Breast J. 26:328-330(2020) PubMed=35011679; DOI=10.3390/cells11010117; PMCID=PMC8749978 Skok K., Gradisnik L., Celesnik H.S., Milojevic M., Potocnik U., Jezernik G., Gorenjak M., Sobocan M., Takac I., Kavalar R., Maver U. MFUM-BrTNBC-1, a newly established patient-derived triple-negative breast cancer cell line: molecular characterisation, genetic stability, and comprehensive comparison with commercial breast cancer cell lines. Cells 11:117.1-117.23(2022) |
Cross-references |
Encyclopedic resources |
Wikidata; Q112129315
|
Entry history |
Entry creation | 17-Mar-2022 |
Last entry update | 19-Dec-2024 |
Version number | 6 |
---|